Automated genotyping of circulating tumor cells

Expert Review of Molecular Diagnostics

Volumn 10, Issue 6, 2010, Pages 723-729

  Stakenborg, Tim ^a   Liu, Chengxun ^a   Henry, Olivier ^b   Borgen, Elin ^c   Laddach, Nadja ^d   Roeser, Tina ^e   Ritzi Lehnert, Marion ^e   Fermér, Christian ^f   Hauch, Sigfried ^g   Osullivan, Ciara K ^b   Lagae, Liesbet ^a  

^a IMEC   (Belgium)

^b UNIVERSITAT ROVIRA I VIRGILI   (Spain)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d MRC HOLLAND   (Netherlands)

^e INSTITUT FÜR MIKROTECHNIK MAINZ GMBH   (Germany)

^f FUJIREBIO INC   (Japan)

^g AdnaGen AG   (Germany)

Author keywords

cancer; cell sorting; circulating tumor cell; DNA amplification; electrochemical sensing; immunomagnetic purification; microfluidics; micrometastasis; multiplex

Indexed keywords

CANCER DIAGNOSIS; CELL COUNT; CELL ISOLATION; CIRCULATING TUMOR CELL; ELECTROCHEMICAL DETECTION; GENE AMPLIFICATION; GENETIC MARKER; GENOTYPE; HUMAN; IMMUNOMAGNETIC SEPARATION; MICROMETASTASIS; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; REVERSE TRANSCRIPTION; REVIEW; TUMOR CELL;

BIOSENSING TECHNIQUES; CELL LINE, TUMOR; ELECTROCHEMICAL TECHNIQUES; GENOTYPE; HUMANS; IMMUNOMAGNETIC SEPARATION; NEOPLASMS; NEOPLASTIC CELLS, CIRCULATING; NUCLEIC ACID AMPLIFICATION TECHNIQUES;

EID: 77956747836     PISSN: 14737159     EISSN: 17448352     Source Type: Journal    
DOI: 10.1586/erm.10.66     Document Type: Review

References (22)

1. Cohen SJ, Punt CJA, Iannotti N et al. Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. J. Clin. Oncol. 26(19), 3213-3221 (2008).
2. Mariella R. Sample preparation: the weak link in microfluidics-based biodetection. Biomed. Microdevices 10(6), 777-784 (2008).
3. Mostert B, Sleijfer S, Foekens JA, Gratama JW. Circulating tumor cells (CTCs): detection methods and their clinical relevance in breast cancer. Cancer Treat. Rev. 35(5), 463-474 (2009).
4. Smerage JB, Hayes DF. The measurement and therapeutic implications of circulating tumour cells in breast cancer. Br. J. Cancer 94(1), 8-12 (2006).
5. Schmitt M, Foekens JA. Circulating tumor cells in blood of primary breast cancer patients assessed by a novel RT-PCR test kit and comparison with status of bone marrow-disseminated tumor cells. Breast Cancer Res. 11(5), 109 (2009).
6. Tewes M, Aktas B, Welt A et al. Molecular profiling and predictive value of circulating tumor cells in patients with metastatic breast cancer: an option for monitoring response to breast cancer related therapies. Breast Cancer Res. Treat. 115(3), 581-590 (2009).
7. Liu CX, Lagae L, Borghs G. Manipulation of magnetic particles on chip by magnetophoretic actuation and dielectrophoretic levitation. Appl. Phys. Lett. 90(18), 184109-1-184109-184113 (2007).
8. Sieuwerts AM, Kraan J, Bolt-de Vries J et al. Molecular characterization of circulating tumor cells in large quantities of contaminating leukocytes by a multiplex real-time PCR. Breast Cancer Res. Treat. 118(3), 455-468 (2009).
9. Henry OY, Acero Sanchez JL, Latta D, OSullivan CK. Electrochemical quantification of DNA amplicons via the detection of non-hybridised guanine bases on low-density electrode arrays. Biosens. Bioelectron. 24(7), 2064-2070 (2009).
10. Henry OY, Fragoso A, Beni V et al. Design and testing of a packaged microfluidic cell for the multiplexed electrochemical detection of cancer markers. Electrophoresis 30(19), 3398-3405 (2009).
11. Van der Auwera I, Peeters D, Benoy IH et al. Circulating tumour cell detection: a direct comparison between the CellSearch System, the AdnaTest and CK-19/mammaglobin RT-PCR in patients with metastatic breast cancer. Br. J. Cancer 102(2), 276-284 (2010).
12. Paterlini-Brechot P, Benali NL. Circulating tumor cells (CTC) detection: clinical impact and future directions. Cancer Lett. 253(2), 180-204 (2007).
13. Rao C, Bui T, Yao Y et al. Automated system to enumerate circulating tumor cells in blood. AACR Meeting Abstracts 2004(1), 763a-776a (2004).
14. Riethdorf S, Fritsche H, Muller V et al. Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system. Clin. Cancer Res. 13(3), 920-928 (2007). (Pubitemid 46340368)
15. Deng G, Herrler M, Burgess D, Manna E, Krag D, Burke JF. Enrichment with anti-cytokeratin alone or combined with anti-EpCAM antibodies significantly increases the sensitivity for circulating tumor cell detection in metastatic breast cancer patients. Breast Cancer Res. 10(4), R69 (2008).
16. Hsieh HB, Marrinucci D, Bethel K et al. High speed detection of circulating tumor cells. Biosens Bioelectron. 21(10), 1893-1899 (2006).
17. Nagrath S, Sequist LV, Maheswaran S et al. Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature 450(7173), 1235-1239 (2007).
18. Talasaz AH, Powell AA, Huber DE et al. Isolating highly enriched populations of circulating epithelial cells and other rare cells from blood using a magnetic sweeper device. Proc. Natl Acad. Sci. USA 106(10), 3970-3975 (2009).
19. Ignatiadis M, Kallergi G, Ntoulia M et al. Prognostic value of the molecular detection of circulating tumor cells using a multimarker reverse transcription-PCR assay for cytokeratin 19, mammaglobin A, and HER2 in early breast cancer. Clin. Cancer Res. 14(9), 2593-2600 (2008).
20. Bolke E, Orth K, Gerber PA et al. Gene expression of circulating tumour cells in breast cancer patients. Eur. J. Med. Res. 14(10), 426-432 (2009).
21. Alix-Panabires C, Vendrell JP, Pelle O et al. Detection and characterization of putative metastatic precursor cells in cancer patients. Clin. Chem. 53(3), 537-539 (2007).
22. Southwest Oncology Group NCI. A randomized Phase III trial to test the strategy of changing therapy versus maintaining therapy for metastatic breast cancer patients who have elevated circulating tumor cell levels at first follow-up assessment (NCT00382018) (2009) www.upmccancercenters.com/trials/ trialDisplay.cfm?id=7377&type=D